Dutra JP et al., 2023: In vitro and in silico characterisation reporting that ivermectin inhibits ABCG2 (breast cancer resistance protein) and behaves as a pan-inhibitor of ABC transporters, i.e. it directly modulates efflux pumps.
Lopinavir and ivermectin can be considered as pan-inhibitors of ABC transporters, since both compounds inhib
n/a (HTML full text)
Dutra JP et al., 2023: In vitro and in silico characterisation reporting that ivermectin inhibits ABCG2 (breast cancer resistance protein) and behaves as a pan-inhibitor of ABC transporters, i.e. it directly modulates efflux pumps. Study type: cell-based efflux assays + molecular modelling. N: n/a. Country: Brazil (Federal University of Parana, Curitiba). Dose: in vitro concentrations, not stated in the retrieved text. Funder/COI: not stated in the PubMed record. Comparator: known ABCG2 inhibitors and untreated cells. Note this paper supports direct transporter inhibition, which contrasts with Jiang 2019 (IVC-29) finding no direct P-gp inhibition – both are recorded. Study type: lab.
